Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9077 |
High Similarity |
NPD1470 |
Approved |
0.8841 |
High Similarity |
NPD5408 |
Approved |
0.8841 |
High Similarity |
NPD5405 |
Approved |
0.8841 |
High Similarity |
NPD5406 |
Approved |
0.8841 |
High Similarity |
NPD5404 |
Approved |
0.8769 |
High Similarity |
NPD1201 |
Approved |
0.8671 |
High Similarity |
NPD7390 |
Discontinued |
0.8633 |
High Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8483 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.8168 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7852 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7808 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7799 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7764 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7736 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7718 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7633 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7615 |
Intermediate Similarity |
NPD2342 |
Discontinued |
0.7589 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7586 |
Intermediate Similarity |
NPD943 |
Approved |
0.7569 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7536 |
Intermediate Similarity |
NPD3019 |
Approved |
0.7481 |
Intermediate Similarity |
NPD5951 |
Approved |
0.7448 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7442 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.744 |
Intermediate Similarity |
NPD8312 |
Approved |
0.744 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7436 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD2798 |
Approved |
0.741 |
Intermediate Similarity |
NPD2932 |
Approved |
0.741 |
Intermediate Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7383 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7383 |
Intermediate Similarity |
NPD3299 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7349 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.731 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7257 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7257 |
Intermediate Similarity |
NPD6534 |
Approved |
0.725 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7248 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7222 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7214 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7205 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.72 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.72 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7179 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7179 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7179 |
Intermediate Similarity |
NPD2532 |
Approved |
0.717 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7125 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7114 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7113 |
Intermediate Similarity |
NPD3023 |
Approved |
0.7113 |
Intermediate Similarity |
NPD3026 |
Approved |
0.7107 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD497 |
Approved |
0.7092 |
Intermediate Similarity |
NPD3024 |
Approved |
0.7092 |
Intermediate Similarity |
NPD3025 |
Approved |
0.7092 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7088 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7088 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7037 |
Intermediate Similarity |
NPD74 |
Approved |
0.7034 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7033 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7033 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7033 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7033 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7032 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.703 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7029 |
Intermediate Similarity |
NPD495 |
Approved |
0.7029 |
Intermediate Similarity |
NPD498 |
Approved |
0.7029 |
Intermediate Similarity |
NPD496 |
Approved |
0.7018 |
Intermediate Similarity |
NPD5029 |
Approved |
0.7018 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD5027 |
Approved |
0.7018 |
Intermediate Similarity |
NPD5031 |
Approved |
0.7014 |
Intermediate Similarity |
NPD4878 |
Approved |
0.7 |
Intermediate Similarity |
NPD9493 |
Approved |
0.6994 |
Remote Similarity |
NPD5402 |
Approved |
0.6978 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6975 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6963 |
Remote Similarity |
NPD9264 |
Approved |
0.6963 |
Remote Similarity |
NPD9267 |
Approved |
0.6963 |
Remote Similarity |
NPD9263 |
Approved |
0.6948 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD2286 |
Discontinued |
0.6918 |
Remote Similarity |
NPD6273 |
Approved |
0.6913 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6913 |
Remote Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6899 |
Remote Similarity |
NPD1511 |
Approved |
0.6894 |
Remote Similarity |
NPD289 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD8438 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6882 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD5034 |
Approved |
0.6879 |
Remote Similarity |
NPD4954 |
Approved |
0.6879 |
Remote Similarity |
NPD36 |
Approved |
0.6879 |
Remote Similarity |
NPD5026 |
Approved |
0.6879 |
Remote Similarity |
NPD5028 |
Approved |
0.6879 |
Remote Similarity |
NPD4955 |
Approved |
0.6871 |
Remote Similarity |
NPD1934 |
Approved |
0.6871 |
Remote Similarity |
NPD1203 |
Approved |
0.6865 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6864 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6861 |
Remote Similarity |
NPD4750 |
Phase 3 |
0.6855 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6846 |
Remote Similarity |
NPD844 |
Approved |
0.6842 |
Remote Similarity |
NPD1932 |
Approved |
0.6839 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6828 |
Remote Similarity |
NPD1281 |
Approved |
0.6828 |
Remote Similarity |
NPD1611 |
Approved |
0.6828 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD6663 |
Approved |
0.6821 |
Remote Similarity |
NPD5030 |
Phase 2 |
0.6818 |
Remote Similarity |
NPD5038 |
Approved |
0.6818 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6818 |
Remote Similarity |
NPD3748 |
Approved |
0.6818 |
Remote Similarity |
NPD5037 |
Approved |
0.6815 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6813 |
Remote Similarity |
NPD1512 |
Approved |
0.6811 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6811 |
Remote Similarity |
NPD8319 |
Approved |
0.6809 |
Remote Similarity |
NPD7874 |
Approved |
0.6809 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6807 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6806 |
Remote Similarity |
NPD4626 |
Approved |
0.6803 |
Remote Similarity |
NPD1876 |
Approved |
0.6794 |
Remote Similarity |
NPD288 |
Approved |
0.6791 |
Remote Similarity |
NPD1930 |
Approved |
0.6791 |
Remote Similarity |
NPD1929 |
Approved |
0.6791 |
Remote Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.6788 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6786 |
Remote Similarity |
NPD4869 |
Clinical (unspecified phase) |
0.6781 |
Remote Similarity |
NPD3972 |
Approved |
0.6779 |
Remote Similarity |
NPD5736 |
Approved |
0.6776 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6774 |
Remote Similarity |
NPD6100 |
Approved |
0.6774 |
Remote Similarity |
NPD2796 |
Approved |
0.6774 |
Remote Similarity |
NPD6099 |
Approved |
0.6772 |
Remote Similarity |
NPD7801 |
Approved |
0.6761 |
Remote Similarity |
NPD5036 |
Approved |
0.6755 |
Remote Similarity |
NPD411 |
Approved |
0.6755 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6752 |
Remote Similarity |
NPD2800 |
Approved |
0.6747 |
Remote Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.6747 |
Remote Similarity |
NPD3882 |
Suspended |
0.6744 |
Remote Similarity |
NPD6020 |
Phase 2 |
0.6742 |
Remote Similarity |
NPD6836 |
Approved |
0.6738 |
Remote Similarity |
NPD9281 |
Approved |
0.6732 |
Remote Similarity |
NPD447 |
Suspended |
0.6727 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6725 |
Remote Similarity |
NPD5033 |
Approved |
0.6715 |
Remote Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.6713 |
Remote Similarity |
NPD7610 |
Discontinued |
0.6709 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6709 |
Remote Similarity |
NPD3400 |
Discontinued |
0.6707 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6692 |
Remote Similarity |
NPD3020 |
Approved |
0.6691 |
Remote Similarity |
NPD4141 |
Clinical (unspecified phase) |
0.669 |
Remote Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.6689 |
Remote Similarity |
NPD6696 |
Suspended |
0.6687 |
Remote Similarity |
NPD2296 |
Approved |
0.6687 |
Remote Similarity |
NPD5616 |
Clinical (unspecified phase) |
0.6686 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6667 |
Remote Similarity |
NPD9717 |
Approved |
0.6667 |
Remote Similarity |
NPD3091 |
Approved |
0.6667
|
Remote Similarity |
NPD9261 |
Approved |